PMID- 37113528 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230430 IS - 1178-6973 (Print) IS - 1178-6973 (Electronic) IS - 1178-6973 (Linking) VI - 16 DP - 2023 TI - Massive Airway Hemorrhage in Severe COVID-19 and the Role of Endotracheal Tube Clamping. PG - 2387-2393 LID - 10.2147/IDR.S378408 [doi] AB - BACKGROUND: Venovenous extracorporeal membrane oxygenation (VV-ECMO) has been widely used in treating patients with coronavirus disease 2019 (COVID-19) with severe respiratory failure. However, there are few reports of the successful treatment of patients with massive airway hemorrhage in severe COVID-19 during VV-ECMO treatment. METHODS: We analyzed the treatment process of a patient with a massive airway hemorrhage in severe COVID-19, who underwent prolonged VV-ECMO treatment. RESULTS: A 59-year-old female patient was admitted to the intensive care unit after being confirmed to have severe acute respiratory syndrome coronavirus 2 infection with severe acute respiratory distress syndrome. VV-ECMO, mechanical ventilation, and prone ventilation were administered. Major airway hemorrhage occurred on day 14 of ECMO treatment; conventional management was ineffective. We provided complete VV-ECMO support, discontinued anticoagulation, disconnected the ventilator, clipped the tracheal intubation, and intervened to embolize the descending bronchial arteries. After the airway hemorrhage stopped, we administered cryotherapy under bronchoscopy, low-dose urokinase locally, and bronchoalveolar lavage in the airway to clear the blood clots. The patient's condition gradually improved; she underwent ECMO weaning and decannulation after 88 days of VV-ECMO treatment, and the membrane oxygenator was changed out four times. She was successfully discharged after 182 days in hospital. CONCLUSION: Massive airway hemorrhage in patients with severe COVID-19 and treated with ECMO is catastrophic. It is feasible to clamp the tracheal tube with the full support of ECMO. Notably, bronchoscopy with cryotherapy is effective for removing blood clots. CI - (c) 2023 Guo et al. FAU - Guo, Litao AU - Guo L AUID- ORCID: 0000-0002-6611-0902 AD - Department of Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China. FAU - Liu, Yu AU - Liu Y AD - Department of Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China. FAU - Zhang, Lei AU - Zhang L AD - Department of Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China. FAU - Li, Qing AU - Li Q AD - Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People's Republic of China. FAU - Qiu, Haibo AU - Qiu H AD - Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People's Republic of China. FAU - Guo, Yaling AU - Guo Y AD - Department of Infectious Diseases, Xi'an Eighth Hospital, Xi'an, People's Republic of China. FAU - Shi, Qindong AU - Shi Q AD - Department of Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China. LA - eng PT - Case Reports DEP - 20230421 PL - New Zealand TA - Infect Drug Resist JT - Infection and drug resistance JID - 101550216 PMC - PMC10128077 OTO - NOTNLM OT - acute respiratory distress syndrome OT - airway hemorrhage OT - coronavirus disease 2019 OT - cryotherapy OT - extracorporeal membrane oxygenation OT - mechanical ventilation COIS- The authors report no conflicts of interest in this work. EDAT- 2023/04/28 06:42 MHDA- 2023/04/28 06:43 PMCR- 2023/04/21 CRDT- 2023/04/28 02:29 PHST- 2023/01/26 00:00 [received] PHST- 2023/04/14 00:00 [accepted] PHST- 2023/04/28 06:43 [medline] PHST- 2023/04/28 06:42 [pubmed] PHST- 2023/04/28 02:29 [entrez] PHST- 2023/04/21 00:00 [pmc-release] AID - 378408 [pii] AID - 10.2147/IDR.S378408 [doi] PST - epublish SO - Infect Drug Resist. 2023 Apr 21;16:2387-2393. doi: 10.2147/IDR.S378408. eCollection 2023.